Miller Financial Services’s Precision BioSciences DTIL Stock Holding History

Miller Financial Services’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,000	Closed	-$93.5K	–	145
2026 Q1	$93.5K	Buy	17,000 +2,000	+13%	+$9.23K	0.1%	115
2025 Q4	$62.4K	Buy	15,000 +5,000	+50%	+$28.4K	0.07%	112
2025 Q3	$55.2K	Hold	10,000	–	–	0.06%	112
2025 Q2	$42K	Hold	10,000	–	–	0.05%	106
2025 Q1	$47.7K	Buy	+10,000	New	+$50.9K	0.07%	93

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Miller Financial Services's DTIL Position: Q2 2026 in Review

Miller Financial Services sold out of Precision BioSciences (DTIL) in Q2 2026, closing a stake of 17,000 shares — an estimated $93.5K sold.

Miller Financial Services first reported a position in DTIL in Q1 2025 and held it in 5 quarters. The position peaked at $93.5K in Q1 2026. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

Miller Financial Services reported no remaining Precision BioSciences position as of Q2 2026 after selling out during the quarter.
Miller Financial Services sold 17,000 Precision BioSciences shares in Q2 2026, an estimated $93.5K.
Miller Financial Services first reported a position in Precision BioSciences in Q1 2025 and held it in 5 quarters.
Miller Financial Services's Precision BioSciences position peaked at $93.5K in Q1 2026.
95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Miller Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.